Healthcare Workers and Vaccine Mandates: Navigating the Evolving Landscape, Implementing and Enforcing Compliance

Ms. Bahlinger is a member of the firm’s Labor and Employment Practice Group and the Manufacturing Sector. She represents clients in all aspects of labor and employment matters, including trial strategy, pleadings and motion practice, discovery, mediation, settlement, trial and appeal. Ms. Bahlinger also has experience litigating and presenting complex matters to government agencies, including the EEOC, DOL and NLRB.

Ms. Faget advises investors, academic medical centers, physician practices, and consultants on a range of business, legal and regulatory issues affecting the telemedicine industry. She helps companies build and refine corporate compliance programs, including advising clients on regulatory and compliance matters involving the Food, Drug and Cosmetic Act, the False Claims Act, the Anti-Kickback Statute, the AdvaMed Code and the PhRMA Code. She regularly drafts and negotiates agreements required for the development and commercialization of pharmaceutical and medical device products, including licensing agreements, collaboration agreements, clinical trial agreements, and an array services agreements.

Ms. King is a member of the firm’s Health Care Practice Group, and a secondary member of the firm’s Government Enforcement, Defense and Investigations Practice Group. She counsels health care providers including health systems, hospitals, clinician practice groups, durable medical equipment companies, clinical laboratories, and telemedicine companies. Ms. King’s work focuses on advising clients with health care regulatory and compliance matters, conducting internal investigations and defending health care clients with government investigations and enforcement actions, including actions arising out of the False Claims Act, Anti-Kickback Statute, and Stark Law. She also assists health care institutions with responding to allegations of scientific and research misconduct. Ms. King has recently been involved in matters involving alleged provider misuse of COVID-19 relief funds, including funds allocated via the Provider Relief Fund, and Health Resources and Services Administration fund for uninsured individuals.

Mr. Vernaglia is the Department Chair for the firm’s Industry Teams Department, responsible for overall strategy and leadership across all industry teams. Prior to that, he served for eight years as chair of the firm’s Health Care Industry Team. Mr. Vernaglia represents hospitals, health systems and academic medical centers, and a variety of other health care providers. His practice involves regulatory and transactional matters, including Medicare/Medicaid reimbursement compliance advice and appeals; mergers, acquisitions and financings; state regulatory issues including licensing, change of ownership, and CoN/DoN; survey/certification appeals; fraud & abuse/Stark law analyses; managed care contracting; and general corporate and business planning in health care. Mr. Vernaglia serves as Outside Policy Counsel for the Massachusetts Health & Hospital Association. He runs strategic planning programs for senior management and governing boards.